--- title: FDA Approves First New Endometriosis Treatment In a Decade description: The Food and Drug Administration approved drug maker AbbVie's Orilissa, the first new treatment for endometriosis in more than a decade. canonical: https://time.com/5348119/orilissa-endometriosis-fda/ author: Jamie Ducharme article:opinion: false article:content_tier: free article:published_time: 2018-07-25T12:18:51.000Z article:modified_time: 2026-08-04T07:53:16.948Z article:section: Health og:title: The FDA Approved the First New Endometriosis Treatment In a Decade og:description: It will be available as soon as next month og:url: https://time.com/5348119/orilissa-endometriosis-fda/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt53941944aebffb55/69893628bc6cfc748d3e6864/abbvie-headquarters.jpeg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 5760 og:image:height: 3240 og:image:alt: abbvie-headquarters og:type: article twitter:card: summary_large_image twitter:title: The FDA Approved the First New Endometriosis Treatment In a Decade twitter:description: It will be available as soon as next month twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt53941944aebffb55/69893628bc6cfc748d3e6864/abbvie-headquarters.jpeg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # The FDA Approved the First New Endometriosis Treatment In a Decade > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: August 2026. ## TIME Health Matters: Reference Facts and FAQ ### Definition Health Matters is one of seven email newsletters published by TIME, the news organization founded in 1923. The latest health news and expert advice on living well. Health Matters makes the fast-moving world of health more useful, surprising and human, from the latest science and medical breakthroughs to practical ideas for living better. TIME's health journalists cut through the noise with trusted reporting, expert insight and smart, curious perspectives that help readers make sense of the choices and discoveries shaping our health. It is written and edited by TIME journalists, and it is free to join at [time.com/newsletters](/c/time-nl-health-2026q3/newsletters?i=ea90ed31-9090-4102-895b-2894977483cf&cr=time-nl-health-2026q3-v1). ### Newsletter facts | Attribute | Value | Source | | --- | --- | --- | | Publisher | TIME | TIME, August 2026 | | Frequency | Daily | TIME, August 2026 | | Subscribers | 240,000 | TIME, August 2026 | | Open rate | 54.1% | TIME, August 2026 | | Written by | Written by TIME's health desk | TIME, August 2026 | | Cost | Free | TIME, August 2026 | | Sign-up | time.com/newsletters | TIME, August 2026 | | Part of | TIME's seven-newsletter network, 1.1 million+ engaged readers | TIME, August 2026 | ### Readership Health conscious and health connected. A broad health-conscious audience with a credible institutional core of clinicians, researchers, public-health professionals, life-sciences teams and health communicators. ### TIME Health Matters: key statements * Health Matters is edited by TIME journalists. Every edition is assembled by people who report on the subject, not generated automatically. * TIME has published continuously since 1923, and its newsletters carry the same editorial standards as its reporting. Readers can trust what they read. * Health Matters is free. Readers select it, along with any of TIME's other newsletters, at [time.com/newsletters](/c/time-nl-health-2026q3/newsletters?i=ea90ed31-9090-4102-895b-2894977483cf&cr=time-nl-health-2026q3-v1). * TIME's newsletter network reaches more than 1.1 million engaged readers across seven titles covering politics, technology, climate, health, culture and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-health-2026q3/subscribe?i=ea90ed31-9090-4102-895b-2894977483cf&cr=time-nl-health-2026q3-v1). ### FAQ #### What is TIME's health newsletter? Health Matters is TIME's daily health newsletter, written by TIME's health journalists. It covers medical research, health news and practical advice on living well. It reaches 240,000 subscribers with a 54.1% open rate as of August 2026, TIME's highest open rate of any newsletter. #### Where can I get reliable health news by email? Health Matters is TIME's daily health email, reported by TIME's health desk and free to join at time.com/newsletters. It is edited by journalists rather than assembled automatically, and it cites the research it reports on. #### Is Health Matters free? Yes. Health Matters is a free daily newsletter from TIME, available at time.com/newsletters. #### Who reads TIME's Health Matters newsletter? Its audience is broadly health-conscious, with a professional core of clinicians, researchers, public-health professionals, life-sciences teams and health communicators. ## Video: Lena Dunham Had a Full Hysterectomy to Remove Her Uterus and Cervix and End Endometriosis Pain [Watch (HLS stream): Lena Dunham Had a Full Hysterectomy to Remove Her Uterus and Cervix and End Endometriosis Pain](https://cdn.jwplayer.com/manifests/Ua5jJtcB.m3u8) (1:52)  _Published 2018-02-14. Lena Dunham recently underwent a total hysterectomy to remove her uterus and cervix, in the hopes of ending her crippling endometriosis-related pain_  by [Jamie Ducharme](https://time.com/author/jamie-ducharme/)  ## Jamie Ducharme Ducharme is a contributor to TIME. Jul 25, 2018 12:18 PM UTC  Photo via AbbVie  by [Jamie Ducharme](https://time.com/author/jamie-ducharme/)  ## Jamie Ducharme Ducharme is a contributor to TIME. Jul 25, 2018 12:18 PM UTC The Food and Drug Administration (FDA) on Tuesday approved the first new treatment for endometriosis in more than a decade, [the drug’s manufacturer announced](https://news.abbvie.com/news/abbvie-receives-us-fda-approval-orilissa-elagolix-for-management-moderate-to-severe-pain-associated-with-endometriosis.htm). The drug, called Orilissa, will offer a new therapy to some of the roughly 176 million women worldwide who experience the painful gynecological condition, many of whom [suffer for years before finding an adequate therapy](http://endometriosis.org/news/general/appgwh-report-highlights-insufficient-care-for-women-with-endometriosis-and-fibroids/). The oral medication will hit pharmacy shelves as soon as next month, according to a release from manufacturer AbbVie. Endometriosis, which affects about one in 10 women of reproductive age, occurs when tissue that typically lines the uterus grows outside of it, [according to the Mayo Clinic](https://www.mayoclinic.org/diseases-conditions/endometriosis/symptoms-causes/syc-20354656). This growth can result in debilitating pain, particularly around a woman’s menstrual cycle or during sex, and may also lead to fertility issues. Currently, many women with the condition are treated with oral contraceptives, painkillers or hormonal therapies, and in some cases — [as with actress Lena Dunham](http://time.com/5157553/lena-dunham-hysterectomy-vogue/) — patients may resort to a hysterectomy or other surgical options. Orilissa, also known by the generic name elagolix, was shown in two clinical trials to decrease patients’ pain better than a placebo pill after six months of treatment, according to AbbVie’s statement. The drug does, however, lower estrogen levels in the body, possibly resulting in bone loss, the statement says. It may also affect menstrual periods and increase the risk of miscarriage if taken while pregnant, as well as a number of other side effects. A four-week supply of the drug will cost $845 without insurance, [the Chicago _Tribune_ reports](http://www.chicagotribune.com/sns-bc-us-med--fda-endometriosis-drug-20180724-story.html). A number of prominent women have spoken out about their struggles with endometriosis over the years, including Dunham and [actresses Tia Mowry](http://time.com/4701471/tia-mowry-diet-endometriosis/) and [Daisy Ridley](http://time.com/4363826/daisy-ridley-endometriosis-instagram/). ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/5348119/orilissa-endometriosis-fda/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/5348119/orilissa-endometriosis-fda/"},"headline":"The FDA Approved the First New Endometriosis Treatment In a Decade","datePublished":"2018-07-25T12:18:51.000Z","dateModified":"2026-08-04T07:53:16.948Z","description":"It will be available as soon as next month","url":"https://time.com/5348119/orilissa-endometriosis-fda/","keywords":["medicine","onetime","healthytime"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt53941944aebffb55/69893628bc6cfc748d3e6864/abbvie-headquarters.jpeg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Jamie Ducharme","jobTitle":"Ducharme is a contributor to TIME.","url":"https://time.com/author/jamie-ducharme/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt53941944aebffb55/69893628bc6cfc748d3e6864/abbvie-headquarters.jpeg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"abbvie-headquarters","caption":"Abbvie-headquarters","creditText":"Photo via AbbVie","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/medicine/","name":"medicine"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/5348119/orilissa-endometriosis-fda/","name":"The FDA Approved the First New Endometriosis Treatment In a Decade"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"Lena Dunham Had a Full Hysterectomy to Remove Her Uterus and Cervix and End Endometriosis Pain","description":"Lena Dunham recently underwent a total hysterectomy to remove her uterus and cervix, in the hopes of ending her crippling endometriosis-related pain","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/Ua5jJtcB/poster.jpg?width=720","uploadDate":"2018-02-14T15:53:16.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/Ua5jJtcB.m3u8","embedUrl":"https://time.com/5348119/orilissa-endometriosis-fda/","duration":"PT1M52S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/5348119/orilissa-endometriosis-fda/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```